- Home
- MOND vs TLSA Comparison
MOND vs TLSA Comparison
Compare MOND & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOND
- TLSA
- Stock Information
- Founded
- MOND 2011
- TLSA 2013
- Country
- MOND United States
- TLSA United Kingdom
- Employees
- MOND N/A
- TLSA N/A
- Industry
- MOND Transportation Services
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- MOND Consumer Discretionary
- TLSA Health Care
- Exchange
- MOND Nasdaq
- TLSA Nasdaq
- Market Cap
- MOND 87.6M
- TLSA 87.8M
- IPO Year
- MOND N/A
- TLSA 2000
- Fundamental
- Price
- MOND $0.98
- TLSA $0.97
- Analyst Decision
- MOND Buy
- TLSA
- Analyst Count
- MOND 4
- TLSA 0
- Target Price
- MOND $3.63
- TLSA N/A
- AVG Volume (30 Days)
- MOND 146.4K
- TLSA 430.1K
- Earning Date
- MOND 11-18-2024
- TLSA 12-27-2024
- Dividend Yield
- MOND N/A
- TLSA N/A
- EPS Growth
- MOND N/A
- TLSA N/A
- EPS
- MOND N/A
- TLSA N/A
- Revenue
- MOND $232,972,000.00
- TLSA N/A
- Revenue This Year
- MOND $11.81
- TLSA N/A
- Revenue Next Year
- MOND $15.08
- TLSA N/A
- P/E Ratio
- MOND N/A
- TLSA N/A
- Revenue Growth
- MOND 28.39
- TLSA N/A
- 52 Week Low
- MOND $0.68
- TLSA $0.41
- 52 Week High
- MOND $3.37
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- MOND 35.29
- TLSA 51.20
- Support Level
- MOND $0.68
- TLSA $0.88
- Resistance Level
- MOND $1.40
- TLSA $1.03
- Average True Range (ATR)
- MOND 0.17
- TLSA 0.09
- MACD
- MOND -0.04
- TLSA 0.01
- Stochastic Oscillator
- MOND 33.62
- TLSA 25.00
About MOND Mondee Holdings Inc.
Mondee Holdings Inc is a travel technology company & marketplace with a portfolio of leisure & corporate travel sectors. The company provides AI platforms, technologies, operating systems, & services that enable travel transactions to serve travelers directly or through travel affiliates. The company has two segments Travel Marketplace & SAAS Platform. The Travel Marketplace segment consists of selling airline tickets through the proprietary platform. The SAAS Platform segment offers corporate travel cost savings solutions through its technology platform. The majority is from the Travel Marketplace segment. Geographically, the key revenue is from the United States.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.